{"url_path":"/sec/txg/10-q/2026/item-3","section_key":"item-3","section_title":"Item 3 Quantitative and Qualitative Disclosures About Market Risk.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1770787/0001628280-26-032388-index.html","accession_number":"0001628280-26-032388","cik":"0001770787","ticker":"TXG","issuer_name":"10x Genomics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1770787/0001628280-26-032388-index.html","primary_entity_key":"0001770787","primary_entity_name":"10x Genomics, Inc."},"word_count":58,"has_tables":true,"body_markdown":"Item 3.    Quantitative and Qualitative Disclosures About Market Risk.\n\nFor financial market risks related to changes in interest rates and foreign currency exchange rates, reference is made to Item 7A “Quantitative and Qualitative Disclosures about Market Risk” contained in Part II of our Annual Report. Our exposure to market risk has not changed materially since December 31, 2025."}